Literature DB >> 15942423

Adherence to antihypertensive treatment: a critical factor for blood pressure control.

Eugenia Ch Yiannakopoulou1, John S Papadopulos, Dennis V Cokkinos, Theodoros D Mountokalakis.   

Abstract

BACKGROUND: To compare rates of blood pressure (BP) control with the level of adherence to antihypertensive treatment and factors influencing compliance in Greek patients.
DESIGN: An observational cross-sectional study on 1000 consecutively treated hypertensive patients, admitted to a University department of general surgery in a Greek hospital.
METHODS: Patients were interviewed by the same doctor using pre-coded questionnaires with questions on demographic data, health and treatment status. Blood pressure was measured using a standard mercury sphygmomanometer. Treatment of hypertension was defined as current use of antihypertensive medication. Compliance was defined as an affirmative reply to a number of questions regarding regular use of antihypertensive medication according to the physician's instructions.
RESULTS: Satisfactory BP control (levels <140/90 mmHg) was documented in only 20% of the treated hypertensives. Compliance to antihypertensive treatment was found in only 15% of the patients. Control of BP was positively associated with compliance. Compliance was more common among patients aged <60, city dwellers, the better educated, those more adequately counselled by their physicians and those followed by a private doctor. As regards treatment, compliance was better among those taking one antihypertensive tablet per day, those who had never changed their antihypertensive regimen and those who had never changed their doctor.
CONCLUSIONS: Compliance is associated with more effective BP control. Physicians can enhance patient compliance and hypertension control by devoting more time to counselling, avoiding unnecessary changes in drug regimens and restricting the tablet numbers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15942423     DOI: 10.1097/00149831-200506000-00010

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  42 in total

1.  Obesity Modifies the Association of Race/Ethnicity with Medication Adherence in the CARDIA Study.

Authors:  Maribel Salas; Catarina I Kiefe; Pamela J Schreiner; Yongin Kim; Lucia Juarez; Sharina D Person; O Dale Williams
Journal:  Patient       Date:  2008-01-01       Impact factor: 3.883

Review 2.  [Adherence to neurologic treatment. Lessons from multiple sclerosis].

Authors:  S Kern; H Reichmann; T Ziemssen
Journal:  Nervenarzt       Date:  2008-08       Impact factor: 1.214

Review 3.  The impact of medication regimen factors on adherence to chronic treatment: a review of literature.

Authors:  Karen S Ingersoll; Jessye Cohen
Journal:  J Behav Med       Date:  2008-01-19

4.  Frequency and predictors of non-compliance to dietary recommendations among hypertensive patients.

Authors:  Muhammad Shahzeb Khan; Faizan Imran Bawany; Arslan Mirza; Mehwish Hussain; Asadullah Khan; Muhammad Nawaz Lashari
Journal:  J Community Health       Date:  2014-08

5.  Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension.

Authors:  Marguerite R Irvin; Daichi Shimbo; Devin M Mann; Kristi Reynolds; Marie Krousel-Wood; Nita A Limdi; Daniel T Lackland; David A Calhoun; Suzanne Oparil; Paul Muntner
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-08-03       Impact factor: 3.738

6.  Racial differences in medication adherence: A cross-sectional study of Medicare enrollees.

Authors:  Ben S Gerber; Young Ik Cho; Ahsan M Arozullah; Shoou-Yih D Lee
Journal:  Am J Geriatr Pharmacother       Date:  2010-04

7.  A Case for a Holistic Approach to the Improvement of Compliance among Hypertensive Patients: A Hospital Review.

Authors:  M Gossell-Williams; J Williams-Johnson; E W Williams; P Levy
Journal:  West Indian Med J       Date:  2014-06-12       Impact factor: 0.171

Review 8.  Improving Adherence to Treatment and Reducing Economic Costs of Hypertension: The Role of Olmesartan-Based Treatment.

Authors:  Francesco Vittorio Costa
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-07-10

Review 9.  Optimal use of beta-blockers in high-risk hypertension: a guide to dosing equivalence.

Authors:  Janet B McGill
Journal:  Vasc Health Risk Manag       Date:  2010-06-01

10.  Effectiveness, safety and cost of drug substitution in hypertension.

Authors:  Atholl Johnston; Panagiotis Stafylas; George S Stergiou
Journal:  Br J Clin Pharmacol       Date:  2010-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.